Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1540 |
|---|---|
| Identifier | NCT05999708 |
| Trial Title | A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: GSK4381406|DRUG: Placebo|DRUG: Indomethacin |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Cambridge |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-10-31 |
|---|---|
| Primary Completion Date | 2024-12-05 |
| Completion Date | 2024-12-05 |